MCQs presented in CLS Flashcards
Which of the following is the most appropriate way to undertake DNA genetic diagnosis of Huntington’s disease?
A- RFLP (restriction fragment length polymorphism) analysis
B- PCR analysis
C- size estimation triplet repeat
D- Southern hybridisation
E- identification of gene-specific mutations
C
The DNA approach to genetic disorders means that individuals who are at risk but clinically asymptomatic can be tested to determine if they will develop the disease. In this circumstance, which one of the following is the most appropriate reason for testing a 9 yo child?
A- informed consent can be obtained from the parents
B- parental anxieties can be relieved
C- In the case of autosomal recessive disorder, the child’s carrier status can be determined
D- Medical intervention can alter the disorder’s natural history
E- the child wants to be tested
D
An 81 year old male presents with dyspnoea. He has a history of cigarette smoking and COPD, and an ejection systolic murmur. Transthoracic echocardiogram shows mild global LV dysfunction (LVEF 49%); aortic maximum velocity (Vmax) 3.4ms-1; PPG 51mmHg; MPG 32mmHg and aortic valve area (AVA) 1.2cm2.
Appropriate management is:
a. Referral for surgical aortic valve replacement
b. Palliative management due to age and comorbidities (COPD, cardiomyopathy)
c. Observation and repeat echocardiography
d. Referral for transcatheter aortic valve replacement (TAVI)
C
Regarding acute severe aortic regurgitation, which of the following are incorrect:
a. Results in a severely dilated left ventricle
b. May be a life-threatening emergency
c. Infective endocarditis is an important cause to consider
d. Bradycardia may lead to patient deterioration
A (is seen in chronic)
Secondary mitral regurgitation is related to
a. Endocarditis with leaflet perforation
b. Mitral valve prolapse
c. Left ventricular dysfunction and annular dilatation
d. Chordal rupture (‘flail leaflet’)
C
An 87 year old man is admitted with a dense left hemiplegia and immobile. Which of the following strategies is the most effective for reducing the risk of developing a pressure ulcer in this patient?
A. Second-hourly turns
B. Assessment of pressure area risk by Norton Risk Assessment Score
C. Nutritional supplementation
D. Indwelling urethral catheterization
E.Pressure relieving mattress
A
Which of the following treatments is most beneficial for venous ulcers?
A. Moist dressings
B. Compression
C. Keeping wound dry and exposed to air
D. Varicose vein surgery
E. Exercise
B
What is the most common cause of chronic leg ulcers?
A. Skin Cancer
B. Arterial disease
C. Venous disease
D. Diabetes
E. Pressure ulcers
C
Which of the following is NOT appropriate therapy for pyoederma gangrenosum
A. Compression
B. Topical tacrolimus
C. Skin grafting
D. Antibiotics
E. Moist wound dressings
C
Which of the following features is NOT useful in distinguishing venous from arterial ulceration:
A.Ulcer shape
B. Ulcer depth
C. Presence of pain
D. ABPI
E. Amount of exudate
C
A patient has cardiac resynchronisation therapy planned. Which of the following investigations will give the best prediction of whether a symptomatic response will be seen?
a. Cardiac MRI
b. Echocardiogram
c. Angiogram
d. CTCA
e. ECG
e
Typical atrial flutter is caused by which mechanism?
a. Increased automaticity of atrial cells
b. Macro-reentry circuit in the atria
c. Micro-reentry circuit in the atria
d. Early after depolarisation
e. Ectopic atrial focus
b
An 88 year old woman with a history of ischaemic heart disease, diabetes, hypertension and depression takes the following medications:
metoprolol 25 mg bd
simvastatin 40 mg daily
aspirin 100 mg daily
metformin 500 mg bd
indapamide 2.5 mg daily
irbesartan 8 mg daily
citalopram 20 mg daily
temazepam 10 mg nocte
Which of the following of her symptoms is most likely to be an adverse drug reaction?
A. Recurrent falls from metformin
B. Memory loss from aspirin
C. Muscle aches from temazepam
D. Confusion from indapamide
E. Leg swelling from citalopram
D - indapamide commonly causes hyponatraemia which causes delirium
30 subjects undergo treatment for cancer. 9 subjects experienced cancer progression at 1 year. Select a true statement from below.
A. The risk of cancer progression on the treatment is 30%.
B. The odds of cancer progression on the treatment are 30%.
C. the NNT is 3.33.
D. The treatment is not effective.
A
Censored observations…
A. can be included in the analysis if we use the correct statistical test.
B. ruin a perfectly good clinical trial.
C. can be excluded from the analysis without making any difference to the conclusions.
D. should be avoided under all circumstances.
A
The following studies (Study A, B, C, D) assess the possible relationship between living near power lines and brain cancer.
Study A
The rate of brain cancer and the proportion of people living near power lines were determined in each Australian state. These rates and proportions were then compared between states.
Study B
A random sample of people were divided into two groups: those who lived near power lines versus those who lived far away. They were followed for ten years. The rates of brain cancer were compared between the two groups.
Study C
A random sample of adult patients who were in hospital over the previous year were divided into two groups: those diagnosed with brain cancer versus those who were not. The proportion of people who previously lived near power lines were compared between the two groups.
Study D
A random sample of people were asked whether they lived near power lines over the previous year and whether they had been diagnosed with brain cancer over the previous year. The rates of brain cancer were compared between those who lived near power lines versus those who lived far away.
List the studies in descending order of strength, i.e. highest quality study first, lowest quality study last.
a. A B C D
b. B C D A
c. C B A D
d. C B D A
B
Which of the following features of clinical trial design may improve efficiency, i.e. less patients needed for the study?
a. stratification
b. allocation concealment
c. crossover
d. intention to treat analysis
C
Covert Oxycodone 30 mg PO BD to CSCI of hydromorphone
- Oxycodone oral morphine equivalent (OME) = 60 x 1.5 = 90 mg
- OME to morphine SC = 90/3 = 30 mg
- Morphine SC to Hydromorphone SC = 30/5 = 6 mg
- Dose reduction when converting to SC = 6 x 2/3 = 4 mg
52F presents with SOB on background resected left breast cancer. CT demonstrates large left sided pleural effusion. What is the next best step in management?
A- therapeutic pleural aspiration
B- diagnostic pleural aspiration
C-antibiotics
D-indwelling pleural catheter
E-intercostal catheter and talc pleurodesis
A: both obtains sample for diagnostic studies and also attempts to see if fluid drainage improves symptoms
A man presents with 2 days of facial pain, redness and swelling. He is systemically well. What is the most appropriate treatment for his condition?
A- oral phenoxymethylpenicillin
B- oral clindamycin
C- IV flucloxacillin
D- IV vancomycin
D- oral amoxicillin + clavulanic acid
A - treatment for erysipelas = superficial infection of skin commonly in face caused by streptococci
A patient presents with severe sepsis, hypotension and a painful, swollen red area on right arm. You suspect necrotising fasciitis. Confirmation of the diagnosis is best made by?
A- presence of crepitus on examination
B- clinical response to IV antibiotics
C- CT imaging of the arm
D- isolation of GAS on blood culture
E- surgical exploration
E
Your local hospital guideline for empiric treatment of acute pyelonephritis (after cultures) recommends IV gentamicin 5 mg/kg LBW Q24H. Which of the following is the most relevant pharmacodynamic parameter to this dosing regimen of gentamicin?
A- Cmax/MIC
B- T > MIC
C- AUC/MIC
D- 0.7 x (Vd/CL)
E- All of the above
A - antibiotic activity of gentamicin (aminoglycaside) is concentration dependent and toxicity is dependent on the total exposure to drug, so aim for high concentration to promote killing and rapid clearance to avoid toxicity
(D is pharmacokinetic)
An MSU positive for E.coli taken from a patient with pyelonephritis who has not responded to IV cefuroxime demonstrates to cepahlosporins + beta-lactams (I for co-amoxyclav). What is the most likely mechanism of resistance to cefuroxime?
A- reduced porin expression
B- enzyme-mediated hydrolysis
C- reduced target binding site affinity
D- efflux pump expression
E- ribosomal methylation
B (mechanism of ESBL)
An MSU positive for E.coli taken from a patient with pyelonephritis who has not responded to IV cefuroxime demonstrates to cepahlosporins + beta-lactams (I for co-amoxyclav). What is the most likely mechanism of resistance to cefuroxime?
A- ampC
B- mecA
C- vanB
D- CTX-M
E- NDM
D (most common type of ESBL worldwide)
(ampC also correct but less common)
67F 2 days dysuria and frequency without systemic involvement. Normal vitals. No drug allergies. Started empirically on trimethoprim, returned positive urine demonstrating broad penicillin resistance (I to co-amoxyclav), susceptibility to ertapenem, gentamicin, fosfomycin and mecillinam.
What is the best outpatient management?
A- OP IV gentamicin Q24H
B- IP IV gentamicin Q24H
C- IP IV ertapenem
D- OP fosfomycin
E- IP fosfomycin
D as treating ESBL+ cystitis (systemically well)
85F presents with series on falls on background of cognitive decline and recurrent UTIs. Denies any LUTS. Oriented and normal vitals. Investigations are unremarkable except for E coli positive MSU pending sensitivities, with Leucs2+ and Nitrite+, urine WCC 120. What is best management?
A- Stat IV gent followed by Q8H cefuroxime
B- Oral trimethoprim
C- observe without antibiotics
D- observe without antibiotics and repeat MSU
E - IV Co-amoxyclav and repeat urine
C - asymptomatic bacteriuria
50F undergoes renal transplantation with ATG induction. She is CMV seronegative but donor is CMV seropositive so is initiated on valganciclovir prophylaxis. After 2 months becomes neutropenic. What is the best method of prevention moving forward?
A- stop valganciclovir and switch to preemptive monitoring with a plan to start treatment when viral load climbs or becomes symptomatic
B- dose reduce valgancliclovir to 450 mg alt days
C- switch prophylaxis to marabivir
D- commence GCSF
E- check CMV IFN-gamma assay to guide duration of prophylaxis
A
30M presents with 4/7 fever and sore throat with 48h itchy vesicular rash, dry cough and SOB. CXR demonstrates diffuse nodular opacities. What specific treatment is appropriate?
A- IV aciclovir
B- IV ceftriaxone
C- PO aciclovir
D- IV ganciclovir
E- IV liposomal amphoteracin
A - symptoms of chickenpox complicated by pneumonia
60M with no PMHx presents with 2/7 headache and altered LOC. No recent travel. On exam she is febrile and drowsy. A CT-head is unremarkable. Her CSF demonstrates 10 lymphocytes, normal glucose and protein 0.5, Gram stain is negative. PCR is awaited.
What is the next most appropriate action?
A- Start IV aciclovir
B- Start IV meropenem
C- Start IV methylprednisone
D- Start IVIg
E- wait until PCR back
A
60F presents with seizure and altered personality. One exam has normal vital signs, is confused and acting abnormally. Bloods are normal and tox screen negative.
Which of the following neuronal antibodies is most likely to be present?
A- anti-mGluR5
B- anti-GABABR
C- anti-Ma2/Ta
D- anti-NMDAR
E- Anti ANNA-1/Hu
D
45M indigenous background is diagnosed with hodkin lymphoma and commenced on R-CHOP. Develops fever, vomiting and diarrhoea, cough, haemoptysis. Has transient infiltrates on serial CXR. Hb 107, WCC 4.5, PLT 112, Eosinophils 1.0.
What is the next step in management of this patient?
A- give platelet transfusion
B- Start IV meropenem
C- urgen bronchoscopy
D- start ivermectin
E- start Frusemide
D - reactivation of strongyloides infection
72M with NHL on R-CHOP presents with fever, tachypnoea, tachycardia and hypotension. Hb 110, Plt 80, Neut 0.2. Which of the following is most appropriate?
A- Amoxicillin clavulanate
B- Ceftriaxone + roxithromycin
C- Ciprofloxacin
D- piperacillin tazobactam
E - vancomycin + gentamicin
D as beta lactam with anti-pseudomonal activity
An ECG is shown demonstrating 2:1 atrial flutter entering into a wide complex tachycardia at 230 bpm. Which of the following is the most likely clinical history associated with this presentation?
A. 70M with prior MI on amiodarone
B. 55F with DCM on ARNI + bisoprolol
C. 44F with pAF on felcainide
D. 18M with history of recurrent SVT
E. 84M with dcPPM for mobitz II AV block
C - flecainide without AV nodal blocking agent increase risk of 1: 1 conduction of A flutter
Which IV antiarrhythmic drug is contraindicated in management of acute VT?
A- lignocaine
B- Verapamil
C- procainamide
D- amiodarone
E- sotalol
B - negative ionotropic effect results in severe hypotension
Which of the following is not a long-term treatment for scar-mediated VT?
A- amiodarone
B - ICD
C- sotalol
D- catheter ablation
E- mexilitene
B - does not treat VT, is prophylactic
A 39 year old mechanic consults you because of concerns about his asthma. Several admissions to hospital in childhood, but none since. Uses Seretide dry powder inhaler (250/50ug), one puff bd. Had a week off work 9 months ago with a chest infection and asthma flare-up which gradually settled. However in the last 2 months has been a little more breathless and wheezy and is waking at night 1-2x per week. Uses salbutamol 2 or 3 times per day. FEV1 73% predicted with 16% improvement post bronchodilator.
Your recommendation:
a. Double the dose of Seretide
b. Change Seretide to metered dose inhaler + spacer
c. Add tiotropium mist inhaler
d. Add montelukast
e. Change to Symbicort SMART (single maintenance and reliever therapy)
f. Other
F - The question describes someone with poor asthma control. In this situation, it is important to first check inhaler technique and adherence to Seretide before increasing inhaler dose or switching to another formulation. Answers a, b, c and e would be reasonable alternatives once adherence and inhaler technique have been checked and optimised. Adding montelukast is unlikely to help unless there is a clear history of aspirin intolerance
A 34 year woman, breastfeeding 6/12 child, is referred by a physician in a large regional town for management of severe asthma. Multiple admissions to hospital, including 3rd trimester of recent pregnancy. Multiple courses of oral prednisolone and recent weight gain. Wakes most nights with wheeze and cough. Allergic rhinitis, previous nasal polyps.
Current treatment Symbicort 400/12ug, ii bd, salbutamol 5-6 per day, oral prednisolone 10mg daily (last 8 weeks). Allergic to house dust mite and moulds, total IgE 520 kU/L, blood eosinophils 0.40 x 10^9/L. FEV1 61% predicted with no significant change after salbutamol.
Your recommendation:
a. Double the dose of Symbicort
b. Change to Seretide via a metered dose inhaler + spacer
c. Add montelukast
d. Refer to immunologist for allergen desensitisation
e. Methotrexate
f. Other
F - The first step would be to check inhaler technique and adherence to Symbicort. The dose of Symbicort is already high so there is not much value in pushing the dose higher. Switching to an alternative ICS/LABA combination metered dose inhaler via a spacer may help. Adding montelukast is unlikely to help unless there is a clear history of aspirin intolerance. Allergen desensitisation should not be initiated in someone with poorly controlled asthma. Methotrexate is too risky in someone who is breastfeeding.
Which of the following is the single most useful test to perform in patients with suspected heart failure?
A- cardiac MRI
B- coronary angiogram
C- Chest x-ray
D- Echocardiogram
D
Most drugs evaluated in HFpEF outcome studies failed to achieve their primary endpoint. Which of the following is an exception?
A- empagliflozin
B- candesartan
C- spirinolactone
D- digoxin
A
A 55-year-old non-smoking male gentleman was referred with an abnormal chest radiograph and an 18-month history of progressive breathlessness. His previously unlimited exercise tolerance had diminished to 300 metres on level ground. He had no infective symptoms, haemoptysis, orthopnoea or paroxysmal nocturnal dyspnoea. He did not have any symptoms of an underlying connective tissue disease (for example Raynaud’s phenomenon, joint or muscle ache, skin tightening, rash, sicca symptoms, mucosal ulcers, alopecia or gastro-oesophageal reflux symptoms). There was no family history of pulmonary disease but his teenage son suffered with chronic aplastic anaemia.
What is the relevance of this patient’s family history? (multiple correct)
a. The absence of a family history of lung disease suggests that the aplastic anaemia affecting his son is not important
b. Childhood aplastic anaemia has no relevance to adult respiratory disease
c. Childhood aplastic anaemia may be related to underlying dyskeratosis congenita (DKC)
d. The family may carry a genetic mutation in the telomerase complex
The correct answers are (c) & (d)
The occurrence of childhood aplastic anaemia raises the possibility of an inherited bone marrow failure syndrome.
Dyskeratosis congenita is caused by mutations in genes encoding proteins involved in the maintenance of telomere length (e.g. telomerase) and manifests with a triad of mucocutaneous features in infancy: nail dystrophy, patchy skin hyperpigmentation and oral leukoplakia.
Aplastic anaemia complicates dyskeratosis congenita in the first or second decade of life.
Telomere shortening as a result of similar mutations has been associated with familial pulmonary fibrosis and emphysema.
What full blood count and biochemistry abnormalities may be encountered in the context of telomere shortening? (multiple can be correct)
a. Anaemia
b. Microcytosis
c. Thrombocytopenia
d. Lymphopenia
e. Deranged liver function tests
The correct answers are (a), (c), (d) and (e)
The most common blood test abnormalities in the context of telomere shortening are:
Anaemia (28%)
Macrocytosis (24-45%)
Thrombocytopenia (9-55%)
Lymphopenia (8%)
Deranged liver function tests (4%)
What other features raise the possibility of shortened telomeres in a patient with pulmonary fibrosis? (multiple can be correct)
a. Liver cirrhosis
b. Premature hair greying
c. Opportunistic infections
d. Emphysema
e. Osteoporosis
The correct answers are (a) – (e) (all are correct)
The clinical features of telomere shortening can involve multiple organs; the effects are in part dependent on the rapidity of tissue turnover.
Manifestations in rapid turnover tissues include:
Premature greying of the hair (20-30 years of age)
Aplastic anaemia, macrocytosis, thrombocytopenia, lymphopenia
B, T and NK cell immunodeficiency resulting in opportunistic infections
Manifestations in slow turnover tissues include:
Pulmonary fibrosis
Premature onset emphysema
Cirrhosis
Coronary artery disease
Osteoporosis
Additional manifestations include an increased risk of epithelial and haematological malignancies.
What genetic phenomenon explains the occurrence of aplastic anaemia in the son and pulmonary fibrosis in the father?
a. Autosomal dominant inheritance
b. X-linked recessive inheritance
c. Mosaicism
d. Anticipation
The correct answer is (d)
The telomere complex mutations are inherited in an autosomal dominant fashion.
Shortened telomeres are carried in germ cells to offspring such that telomeres start from a shortened length in successive generations.
This leads to an anticipation effect with the onset of disease becoming earlier in successive generations.
Phenotype transition can occur, as exemplified in this case, with offspring presenting with haematological manifestations rather than respiratory disease – this explains the interesting occurrence of pulmonary fibrosis in this patient developing after the onset of haematological disease in his son.
The disease phenotype can also become more severe in successive generations.
This phenomenon raises important issues for genetic counselling in affected families.
Which of the following features are shared between Idiopathic Pulmonary Fibrosis (IPF) and Rheumatoid Arthritis associated Interstitial Lung Disease (RA-ILD)? (multiple can be correct)
a. Usual interstitial pneumonia (UIP) radiological pattern
b. MUC5b genetic mutation
c. Association with a smoking history
d. Acute exacerbations
e. Response to anti-fibrotic therapy
The correct answers are (a), (b), (c) and (d)
The efficacy of anti-fibrotics in RA-ILD are not yet proven – the results of the TRAIL1 study are eagerly awaited. INBUILD [ahead of print] may provide some support for nintedanib in RA-ILD.
RA-ILD differs from other CTD-ILD in its predisposition to a UIP radiological/histological pattern.
A gain of function mutation in MUC5b is observed in ~50% of IPF patients. The same mutation has been found to increase the risk of ILD in RA.
The risk of RA-ILD is increased by a history of smoking. RA-ILD acute exacerbations are similar to acute exacerbations of IPF and have a high risk for mortality.
Which of the following therapies does not have proven efficacy in systemic sclerosis associated interstitial lung disease?
a. Cyclophosphamide
b. Mycophenolate
c. Autologous stem cell transplantation
d. Nintedanib
e. Methotrexate
The correct answer is (e)
The pivotal Scleroderma Lung Study (SLS) trials confirmed the efficacy of cyclophosphamide and mycophenolate.
A number of recent trials have confirmed the efficacy of autologous stem cell transplantation in appropriately selected patients.
The SENSCIS trial recently confirmed the efficacy of nintedanib on rate of FVC decline in SSc-ILD.
Methotrexate has not been studied in SSc-ILD and would typically be avoided in SSc-ILD due to its risk of causing ILD.
Which of the following therapies should be avoided in a patient with Idiopathic Pulmonary Fibrosis (IPF)? (multiple correct)
a. Pirfenidone
b. Nintedanib
c. Azathioprine
d. N-acetylcysteine
e. Mycophenolate
The correct answers are (c) and (e)
Both pirfenidone and nintedanib have proven efficacy in IPF.
N-acetylcysteine is not commonly used in IPF, however there may be efficacy in those who carry a mutation in TOLLIP.
The combination of azathioprine, prednisolone and n-acetylcysteine was shown to be harmful in those with IPF (PANTHER). Similar data exists for mycophenolate in IPF. Immunosuppression is therefore strongly discouraged in patients with IPF. The only exception may be in those with acute exacerbations of IPF where high dose corticosteroids might be utilized.
A 45 year old lady presents with type 1 respiratory failure and the CT scan attached. She has no known medical history. Examination of the hands reveals erythematous lesions symmetrically over the meta-carpophalangeal joints. Her CK is not elevated. She is started on high flow oxygen therapy at 60% FiO2 and stabilized on the ward.
What is the most important next step in management of this patient?
a. Await ENA result
b. Await myositis panel result
c. Bronchoscopy with bronchoalveolar lavage
d. Commence immunosuppression
e. Start broad spectrum antibiotic therapy
The correct answer is (d)
This lady has a severe dermatomyositis associated interstitial lung disease. In this particular case the patient has an anti-MDA5 antibody which is typically amyopathic (hence the negative CK) and a pneumomediastinum (a common complication of this disease). The constellation of skin and lung findings is sufficient for the diagnosis and therefore the antibody panel is not necessary before the commencement of treatment.
A bronchoscopy is not required to make the diagnosis and would also be highly risky in the patient’s current clinical circumstance.
Which of the following is a good prognostic feature in hypersensitivity pneumonitis?
a. Presence of honeycombing on CT
b. Identifiable antigen exposure
c. Shortened telomeres
d. Biopsy pattern of UIP
e. Negative serum precipitins
The correct answer is (b)
An identifiable exposure allows that patient to avoid/remove the exposure which is causing inflammation and fibrosis. An exposure is not identifiable in ~25% of patients with chronic hypersensitivity pneumonitis. The lack of an identifiable exposure is a poor prognostic feature.
The presence of honeycombing, UIP and shortened telomeres are poor prognostic features.
Serum precipitins may be useful in diagnosing HP, but are not contributory to prognostication. Serum precipitins may assist in defining an exposure.
A 50 year old male smoker presents with dyspnoea and the attached chest x-ray. An intercostal catheter is inserted. A CT is performed.
The presence of which cells in a lung biopsy would confirm this man’s diagnosis?
a. Fibroblasts
b. LAM cells
c. Macrophages
d. CD1a+ Langerhans cells
e. Pneumocystis
The answer is (d)
This man has Langerhans cell histiocytosis as the cause of his cystic lung disease. Langerhans cells are dendritic cells which is diagnostic of this condition.
The CT demonstrates multiple irregularly shaped cysts within the lung. Sparing of the costophrenic recesses (not shown) is classic of this condition. Whereas in LAM the cysts are typically found in the costophrenic recesses - ‘LAMbs fall to the gullies’. The cysts in LAM typically have a smooth outline.
An 80 year old lady presents to outpatients with chronic cough and dyspnoea and the attached chest CT. She has a past history of hypertension, dyslipidaemia, type 2 diabetes, chronic kidney disease and recurrent urinary tract infections.
Which of the below medications is the most likely cause?
a. Perindopril
b. Atorvastatin
c. Nitrofurantoin
d. Metoprolol
e. Metformin
The correct answer is (c)
This is a classic scan for nitrofurantoin induced lung disease. The RACP candidate would not be expected to know this classic scan appearance but should be aware of common causes of drug induced ILD (e.g. amiodarone, nitrofurantoin, methotrexate, newer biologic therapies).
This 39 year old lady with a history of recurrent sinus infections presents with chronic dyspnoea and an abnormal chest CT. The below investigation results are obtained:
Lung function: FEV1 60%, FVC 80%, FEV1/VC 64%
ANA: 1:180 speckled
ENA: negative
Myositis panel: negative
ACE: elevated
ANCA: negative
RF: negative
Which of the following investigations should be performed next to diagnose this interstitial lung disease?
a. Surgical lung biopsy
b. EBUS-TBNA
c. Serum immunoglobulin levels
d. Bronchoalveolar lavage
e. CT guided percutaneous lung biopsy
The answer is (c)
This lady has Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) associated with Common Variable Immunodeficiency (CVID). The history of recurrent sinus infections is the clue to this diagnosis. GLILD is a rare interstitial lung disease that can mimic sarcoidosis.
A bronchoalveolar lavage may be required to exclude atypical infection complicating this condition
A 35 year old female with a history of previous pneumothorax and the attached CT has had progressive decline in her FEV1 over the last 5 years.
Which of the below therapies has proven efficacy in this condition to slow lung function decline?
a. Pirfenidone
b. Sirolimus
c. Inhaled corticosteroids
d. Mycophenolate
e. Oestrogen
The correct answer is (b)
This patient has lymphangioleiomyomatosis. The combination of pulmonary cysts and renal angiomyolipoma in a young woman is a classic presentation.
There are sporadic and tuberous sclerosis associated forms.
High VEGF-D levels may assist in diagnosis in difficult cases.
Rapamycin (mTOR inhibitor) has been shown to slow lung function decline in this condition.
A 68 year old male presents with chronic cough and dyspnoea. His CT scan is reported as demonstrating bilateral lower zone ‘crazy-paving’. A bronchoalveolar lavage has returned ‘milky’ fluid which is periodic acid Schiff positive.
Presence of which of the below antibodies would be suspected?
a. Anti-GM-CSF
b. MPO-ANCA
c. PR3-ANCA
d. Anti-Jo1
e. Anti-MDA5
The correct answer is (a)
The features in this case are suggestive of Pulmonary Alveolar Proteinosis (PAP).
PAP results from the accumulation of surfactant in alveoli due to impaired clearance by alveolar macrophages. There are primary and secondary forms. The auto-immune (primary) form accounts for 90% of cases and is characterized by antibodies to GM-CSF.
The treatment options include whole lung lavage, immunomodulation and inhaled GM-CSF.
TRAB antibodies should be measured in pregnant women with past history of Graves’ Disease. True or False?
True, Maternal TRAb serum concentration greater than 3 times the upper limit of the reference range in the third trimester is a risk factor for neonatal hyperthyroidism
TPO antibodies should be measured in pregnant women to guide thyroid treatment.
True or False?
False
T3 levels are important for transplacental transfer and fetal thyroid needs. True or False?
False
When pregnant, women with hypothyroidism require thyroxine dose adjustment. True or False?
True
Hypothyroidism in pregnancy is diagnosed as TSH >5 or TSH > pregnancy reference range and low T4. True or False?
True
A 70 year old woman was admitted with an exacerbation heart failure and four days later had developed a purpuric rash on her legs and renal impairment. The most important first test is:
a. ANCA
b. Urine test for haematuria
c. A renal biopsy
d. Examination of her drug chart especially for medications containing an S group
b. Urine test for haematuria
If this is present, the person may have microscopic polyangiitis. If there is no haematuria, then this may be a reaction to a medication, such as furosemide in this case. Even though she may have been on this for years, an increase in dose may precipitate purpura. In this case, stop the furosemide and switch to bumetanide once a day.
45F developed focal seizures with secondary generalization after a closed head injury in an MVA. She was started on lamotrigine monotherapy, which resulted in a significant decrease in seizure frequency but not complete control. Sometimes she misses a dose. The dose is uptitrated to the point she has developed side effects of mild blurred vision. She does not wish to stop lamotrigine.
Which of the following agents would be most appropriate to add as a second agent?
A- carbamazepine
B- Eslicarbazepine
C- levetiracetam
D- oxcarbazepine
E- Phenytoin
C- levetiracetam, is only agent that does not share mechanism of action with lamotrigine (binds SVA2 rather than blocking sodium channel)
Recognised methods for managing ARDS include
a. Use of high frequency oscillation
b. Low PEEP and high tidal volumes
c. High Driving pressures
d. Prone ventilation
e. All of the above
d. Prone ventilation
Use of long term oxygen therapy in chronic respiratory failure
a. Definitively increases physical activity
b. Reduces overall mortality when given nocturnally
c. Definitively increases physical activity
d. Should be administered for at least 15 hours per day to be effective
e. All of the above
d. Should be administered for at least 15 hours per day to be effective
Non-invasive ventilation in neuromuscular disease
a. Is most effective when commenced electively for incipent respiratory failure as opposed for critically ill presentations in respiratory failure
b. Is most effective in motor neurone disease when commenced in patients with normal or mildly impaired bulbar function
c. Is most effective in patients with chest wall deformities
d. a,b,c above
e. None of the above
d. a,b,c above
Management of respiratory failure should include
a. Use of cough assist devices when sputum clearance is impaired
b. Use of extracorporeal support when PEEP is greater than 10 cm H2O
c. Routine use of oxygen to improve mobility in exercise induced hypoxaemia
d. Regular use of oxygen therapy for nocturnal episodic hypoxaemia
e. a and c above
e. and c above
Which of the following is not a cause of microcytic anaemia?
A- B thalassemia trait
B- alcohol excess
C- sideroblastic anaemia
D- lead poisoning
E- iron deficiency
B- alcohol excess
(lead poisoning interferes with heme synthesis)